Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2018 Mar;7(Suppl 1):S128-S131.
doi: 10.21037/tau.2017.10.07.

Balancing the benefits and harms of radiotherapy post-radical prostatectomy

Benjamin W Lamb  1 , Omar Alghazo  1 , Declan G Murphy  1   2
Affiliations
Editorial

Balancing the benefits and harms of radiotherapy post-radical prostatectomy

Benjamin W Lamb et al. Transl Androl Urol. 2018 Mar.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Figures

Figure 1
Figure 1
Image from urethroscopy depicting bladder neck stenosis in a patient who had undergone salvage radiotherapy for a rising PSA following RARP. PSA, prostate-specific antigen; RARP, robot-assisted radical prostatectomy.
Figure 2
Figure 2
Axial section from F-18 prostate-specific membrane antigen (DCFPyL) PET/CT in a 58-year-old man with rising PSA (3.31 ng/mL) following radical prostatectomy. Image shows moderate PSMA uptake in a left sided para-aortic lymph node at the level of the L3 vertebral body (white arrow). The lower pole of the right kidney is also visible (black arrow). Scan performed on GE Discovery 690 with time-of-flight. PSA, prostate-specific antigen; PSMA, prostate-specific membrane antigen.
See this image and copyright information in PMC

Comment on

References

    1. Wallis CJ, Glaser A, Hu JC, et al. Survival and Complications Following Surgery and Radiation for Localized Prostate Cancer: An International Collaborative Review. Eur Urol 2018;73:11-20. 10.1016/j.eururo.2017.05.055 - DOI - PubMed
    1. Fossati N, Karnes RJ, Colicchia M, et al. Impact of Early Salvage Radiation Therapy in Patients with Persistently Elevated or Rising Prostate-specific Antigen After Radical Prostatectomy. Eur Urol 2017. 10.1016/j.eururo.2016.07.028 - DOI - PubMed
    1. Boorjian SA, Thompson RH, Tollefson MK, et al. Long-term risk of clinical progression after biochemical recurrence following radical prostatectomy: the impact of time from surgery to recurrence. Eur Urol 2011;59:893-9. 10.1016/j.eururo.2011.02.026 - DOI - PubMed
    1. Pound CR, Partin AW, Eisenberger MA, et al. Natural history of progression after PSA elevation following radical prostatectomy. JAMA 1999;281:1591-7. 10.1001/jama.281.17.1591 - DOI - PubMed
    1. Trock BJ, Han M, Freedland SJ, et al. Prostate cancer-specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after radical prostatectomy. JAMA 2008;299:2760-9. 10.1001/jama.299.23.2760 - DOI - PMC - PubMed

LinkOut - more resources